Page last updated: 2024-10-29

ketanserin and Colonic Neoplasms

ketanserin has been researched along with Colonic Neoplasms in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Colonic Neoplasms: Tumors or cancer of the COLON.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Curtis, JJ1
Vo, NTK1
Seymour, CB1
Mothersill, CE1

Other Studies

1 other study available for ketanserin and Colonic Neoplasms

ArticleYear
5-HT
    International journal of radiation biology, 2020, Volume: 96, Issue:4

    Topics: Bystander Effect; Cell Death; Colonic Neoplasms; HCT116 Cells; Humans; Ketanserin; Ondansetron; Radi

2020